0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Stage
Employees
Links
View full screen
Hugh Y. Rienhoff, Jr.
View all
5 members
Coherus BioSciences
5 followers
BioMarin Pharmaceutical
20 followers
Adaptive Biotechnologies
11 followers
Eikon Therapeutics
1 follower
Dragonfly Therapeutics
Discover companies